Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021

IOT Insider Trading (Innovotech)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$8,470.00
Insider Selling (Last 12 Months): C$0.00

Innovotech Insider Trading History Chart

Innovotech Share Price & Price History

C$0.16
▲ +0.005 (3.23%)
As of 06/22/2021 10:30 AM ET
Days: 30 | 90 | 365
One pot stock could skyrocket with looming interstate sales
A new bill in Congress would decriminalize marijuana nationally by removing cannabis from the federal government’s list of controlled substances. The law would also allow one established Seattle cannabis company to market across state lines for the first time – potentially setting off a bidding war that could blast this stock into the stratosphere!
Find Out Why This Could Be the #1 Pot Stock

Innovotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/29/2021James Gregory TimourianSenior OfficerBuy20,000C$0.16C$3,200.001,920,920
2/25/2021James Gregory TimourianSenior OfficerBuy14,000C$0.18C$2,520.001,900,920
6/24/2020Alan Clyde Hayes SavageInsiderBuy25,000C$0.11C$2,750.0075,000
12/6/2018Alan Clyde Hayes SavageInsiderBuy14,000C$0.05C$700.00
12/4/2018Alan Clyde Hayes SavageInsiderBuy100,000C$0.05C$5,000.00
11/30/2018Alan Clyde Hayes SavageInsiderBuy100,000C$0.06C$6,000.00
11/19/2018Alan Clyde Hayes SavageInsiderBuy100,000C$0.06C$6,000.00
11/16/2018Alan Clyde Hayes SavageInsiderBuy70,000C$0.05C$3,500.00
11/14/2018Alan Clyde Hayes SavageInsiderBuy100,000C$0.05C$5,000.00
9/25/2018Alan Clyde Hayes SavageInsiderBuy23,000C$0.05C$1,150.00
9/17/2018Alan Clyde Hayes SavageInsiderBuy27,000C$0.05C$1,350.00
See Full Table
Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally. The company offers InnovoSIL, an antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. It also provides implant medical devices; antibiotic, antimicrobial, and biocide resistance; bacteriophage, cytotoxicity, and in vitro antimicrobial testing; and analytical services. Innovotech Inc. serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. The company was incorporated in 2001 is headquartered in Edmonton, Canada.
Read More on Innovotech

Today's Range

Now: C$0.16
C$0.16
C$0.16

50 Day Range

MA: C$0.15
C$0.14
C$0.17

52 Week Range

Now: C$0.16
C$0.14
C$0.30

Volume

600 shs

Average Volume

35,283 shs

Market Capitalization

C$6.23 million

P/E Ratio

26.67

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Innovotech?

Innovotech's top insider shareholders include:
  1. James Gregory Timourian (Senior Officer)
  2. Alan Clyde Hayes Savage (Insider)
Invest In Psychedelic Therapy?
Psychedelic Therapy Clinics are popping up all over LA and Arizona. Some of them charge up to $2,000 for a full treatment... this is an emerging trend every investor should consider.
Tell Me More About Psychedelic Therapy